TAKEDA PHARMA A/S: Financial statements 2019
CVR: 16406899
Source: annual report 2019, Danish Business Authority
01/04/2018 – 31/03/2019
TAKEDA PHARMA A/S (CVR 16406899) has filed annual accounts for 2019. In 2019, the company reported revenue of DKK 1,571,272,000 and a net result of DKK 84,680,112,000 compared with DKK 595,839,000 the year before. That is a decrease of 11.8% compared with the year before. The profit margin was 5,389.3%. Equity in the 2019 report amounted to DKK 1,314,274,000. The solvency ratio was 85%. The company had 177 employees in the financial year.
- Revenue
- DKK 1,571,272,000
- Gross Profit
- DKK 562,304,000
- Profit/Loss
- DKK 84,680,112,000
- Equity
- DKK 1,314,274,000
- Total Assets
- DKK 1,546,951,000
- Employees
- 177
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2019 | 1.6 mia. | 562.3 mio. | 84.7 mia. | 1.3 mia. | 177 |
| 2018 | 1.8 mia. | 712.1 mio. | 595.8 mio. | 100.5 mia. | 197 |
| 2017 | 1.7 mia. | 626 mio. | -102.6 mio. | 99.9 mia. | 305 |
| 2016 | 1.7 mia. | 212.5 mio. | 25.3 mia. | 100.2 mia. | 488 |
Official annual report
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningEvents in 2019
As of August 13, 2019, Jesper Lindahl has joined the board of directors of TAKEDA PHARMA A/S.
As of August 13, 2019, Marianne Hauge has left the board of directors of TAKEDA PHARMA A/S.
As of August 12, 2019, Jesper Lindahl has left the board of directors of TAKEDA PHARMA A/S.
As of February 15, 2019, is registered as an owner of TAKEDA PHARMA A/S with an ownership share of 100%.
About TAKEDA PHARMA A/S
TAKEDA PHARMA A/S is a Danish company of the type Aktieselskab based in Vallensbæk Strand, founded in 1984. The company is registered under the industry Engroshandel med medicinalvarer og sygeplejeartikler. The company was previously named NYCOMED DANMARK ApS and NYCOMED DANMARK A/S. The management consists of Enor Cerimagic. The board consists of Koki Sato (chair), Enor Cerimagic, Jesper Lindahl and Malene Kelstrup. The company is owned by Takeda Pharmaceuticals International AG. The company has 79 employees (2026). In 2026, the company reported revenue of DKK 1,112,753,000 and a net result of DKK 88,641,000 compared with DKK 12,162,000 the year before. Equity in the 2026 report amounted to DKK 456,501,000.